Abstract
The historic wildfires of August and September 2020, up and down the west coast have made Western cities in the U.S. rank among the highest in the world for dirtiest air. Washington State was impacted by active wildfire smoke in the state as well as transported aged wood smoke from Oregon and California. Particulate matter smaller than 2.5 μm in aerodynamic diameter (PM2.5) is the primary pollutant from wildfire smoke of health concern for the public. This study aims to assess the potential population health impact of increased PM2.5 concentrations attributable to the wildfire smoke. Daily PM2.5 concentrations for each county before and during the 2020 Washington state wildfire smoke episode was obtained from the WA Department of Ecology. Utilizing previously established associations of short-term mortality and PM2.5 concentrations we estimated increases in all-cause, respiratory, and cardiovascular mortality for Washington state attributable to the increased PM2.5 levels during the wildfire episode. During the episode, PM2.5 concentrations increased 99.4 μg/m3 on average in Washington. Each week of wildfire smoke exposures are estimated to cause 91.0 (95% CI: 73.8, 107.1) cases of increased all-cause mortality, 19.9 (95% CI: 10.4, 29.3) increased cardiovascular disease deaths, and 9.7 (95% CI: 5.4, 14.0) increased respiratory disease deaths. This is without considering the coincidence with the COVID-19 pandemic, since wildfire smoke exposure may exacerbate the effects of SARS-CoV-2 infection based on some early evidence. Because wildfire smoke episodes are likely to continue impacting the Pacific Northwest in years to come, continued preparedness and mitigations to reduce exposures to wildfire smoke are necessary to avoid this excess health burden.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is supported in part by NIH grant 5P30 ES007033-23 and the China Scholarship Council for the Fellowship funding to YL.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was not required for this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are openly available in Washington Department of Ecology (https://enviwa.ecology.wa.gov/Report/Hr24PM25SummaryNew), and the U.S. Census Bureau (https://www.census.gov/data/datasets/time-series/demo/popest/2010s-counties-total.html).
